Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMPULS
2023-506553-37-00Phase 2Authorised
- Sponsor
- Zealand University Hospital
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in pancreatic adenocarcinoma (PDAC) comparing Propranolol preoperative arm with Placebo preoperative arm (2 arms). Primary endpoints: Change in preoperative anxiety levels (HAM-A), Change in anxiety and depression (HADS) and 5 more. Planned start Apr 2024; status: authorised.
02
Drugs
propranolol
03
Conditions
pancreatic adenocarcinoma (PDAC)
Beyond the preview
Go deeper on 2023-506553-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2023-506553-37-00.